In clinical trials, how do you determine whether the baseline characteristics of your treatment and control groups are comparable? I recently analyzed a dataset where subtle differences in age and gender ratios impacted the interpretation of results significantly. It made me wonder how often these factors are overlooked, and I’m interested in hearing how others approach this aspect of trial design.